Oil prices spiked over 10% to $96.50/barrel, sparking a short squeeze as markets reprice Iran war risk 6.
Even the globe’s most powerful navy struggles to secure the Strait of Hormuz, highlighting critical geopolitical chokepoints 7.
The 572 million barrels (~30% of total US/IEA reserves) released from strategic oil reserves are deemed insufficient to offset 20 million barrels of daily disruption 10.
Iran’s recurring “K.E.B.A.B.” (Keeps Escalating But Always Backs-off) pattern on geopolitical issues like Hormuz Strait suggests a predictable, yet volatile, strategy 12.
Q1 (Dec-Mar) saw pure rotation; the Israel-US-Iran conflict has made oil the prime risk gauge. Stocks can’t catch a bid, rendering the market utterly unreliable. Crypto is flatlining, while gold and silver have already run hot 3.
Being excessively bearish or heavily short near midterms is a high-risk play; a Trump administration dovish pivot or war exit could lead to a massive short squeeze 5.
A trivial political “message” (metaphor for a non-event) somehow tanked US equities, showcasing extreme market irrationality 2.
$VIX hitting 26.77 signals significantly elevated volatility, making for a choppy trading environment 4.
“Young Master Ou” is portrayed as financially struggling, relying on gestures for payments and unable to cover expenses without micro-loans 15.
While Tower has potential, TSMC remains the undisputed “TSMC of photonics,” with COUPE technology holding an unmatchable edge 1.
Anthropic’s strategic venture with $BX to offer Claude models and implementation support creates a direct pipeline for rapid enterprise AI adoption 14.
@grvt_io’s TGE is pushed to late June, with full tokenomics now live. The prime crypto narrative this year is Real World Asset (RWA) migration; GRVT is positioned to capitalize by targeting stock tokens, FX, and commodities 9.
$ADUR is consolidating near $10 support on drying volume. A breakout above $14 could unlock a $21 target, even if it runs 20% to get there; a clear bullish setup 11.
$XLF Financials are in “free fall” territory, logging 9 down days out of the last 10, with RSI plummeting below 30. The market is hunting for a bounce 13.
#HIMS onboarding a VP of Regulatory Compliance highlights compliance as a mission-critical pillar for biotech/pharma, promising more operational stability 8.